Skin Health Clinical Trial
Official title:
A Clinical Trial to Determine the Activity of Dealcoholized Muscadine Wine to Alleviate Oxidative Stress, Inflammation, Skin Photoaging, and Alter the Gut Microbiome in Women 40-67
The objective of this clinical trial is to determine the activity of dealcoholized muscadine wine to alleviate oxidative stress, inflammation, skin photoaging, and alter gut microbiome in women 40-67 years of age. The investigators hypothesize that dealcoholized muscadine wine daily for 42 days will significantly alleviate oxidative stress, inflammation, skin photoaging, and alter the gut microbiome in women compared to drinking sugar water.
Aging of the skin is characterized by wrinkling, sagging, and laxity. About 80% of facial skin aging is classified as extrinsic, or photoaging because it results from exposure to UV light of the sun that causes oxidative stress The remaining 20% of facial aging is the intrinsic type which is partially caused by the accumulation of proteins that are modified by reactive carbonyls in a reaction known as protein glycation. Aging also shifts the composition of the gut microbiome in at least 35 genera towards an unhealthy state of dysbiosis. Previous studies showed that muscadine polyphenols inhibited protein glycation under a simulated physiological condition. Additional experiments using cell culture and mice showed that dealcoholized muscadine wine alleviated inflammation and protected against dysbiosis in the gut. The objective of this research is to confirm the health benefits of muscadine wine polyphenols in a clinical trial. The investigators hypothesize that dealcoholized muscadine wine consumption in women 40-65 years old will alleviate skin photoaging and skin conditions by decreasing oxidative stress and inflammation. It is also expected to improve the composition of the gut microbiome. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04544982 -
Study to Evaluate the Efficacy of Blue Fenugreek Kale Extract (BFKE) on Skin
|
N/A | |
Completed |
NCT03346447 -
Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation
|
N/A | |
Completed |
NCT05861622 -
Examining the Efficacy of a Novel Moisturizer Across Eight Weeks
|
N/A | |
Recruiting |
NCT06148740 -
An Investigation of the Effects of a Skin Serum Containing Propolis on Skin Health and Appearance
|
N/A | |
Active, not recruiting |
NCT06148766 -
An Investigation of the Effects of a Royal Jelly and Bee Venom-Derived Skin Cream on Skin Health and Signs of Aging
|
N/A | |
Active, not recruiting |
NCT06148753 -
An Investigation of the Effects of a Royal Jelly and Bee Venom-Derived Skin Serum on Skin Health and Signs of Aging
|
N/A | |
Completed |
NCT04511052 -
Probiotics for Enhanced Tissue Carotenoid Status in Premenopausal Women
|
Phase 1/Phase 2 | |
Recruiting |
NCT05925712 -
Aerofit Post Market Investigation
|
N/A | |
Completed |
NCT02525224 -
Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults
|
N/A | |
Completed |
NCT04144777 -
Efficacy of Solarplast for Health and Oxidative Stress
|
N/A | |
Recruiting |
NCT04861623 -
Effects of 100% Orange Juice on Skin Health in Women
|
N/A | |
Completed |
NCT03771807 -
Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults
|
N/A | |
Recruiting |
NCT04183920 -
To Determine the Activity and Mechanisms of Cranberries to Attenuate Skin Photoaging and Improve Skin Health in Women
|
N/A | |
Completed |
NCT06452810 -
A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area
|
N/A | |
Completed |
NCT00864188 -
The Influence of Probiotics in a Drinkable Yogurt on Skin Health
|
Phase 1 | |
Completed |
NCT03348917 -
The Effect of Skin Cleansers on the Skin Surface Microbiome
|
Phase 4 | |
Withdrawn |
NCT03641430 -
The Effects of Over-the-Counter Products on the Skin
|
N/A | |
Recruiting |
NCT05128240 -
Nutritional Study of Fish Oil in Skin Quality in Healthy Women
|
N/A | |
Completed |
NCT00574574 -
Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk
|
N/A |